Strategic importance of Research support through pathology : Discovery pathology: Compound selection and early developmentCOCKERELL, Gary L; MCKIM, James M; VONDERFECHT, Steven L et al.Toxicologic pathology. 2002, Vol 30, Num 1, pp 4-7, issn 0192-6233Article

Nonclinical Safety Evaluation of Sunitinib : A Potent Inhibitor of VEGF, PDGF, KIT, FLT3, and RET ReceptorsPATYNA, Shem; ARRIGONI, Claudio; TERRON, Andrea et al.Toxicologic pathology. 2008, Vol 36, Num 7, pp 905-916, issn 0192-6233, 12 p.Article